{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:15:32Z","timestamp":1760188532001},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,7,26]],"date-time":"2005-07-26T00:00:00Z","timestamp":1122336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00134-005-2736-8","type":"journal-article","created":{"date-parts":[[2005,7,25]],"date-time":"2005-07-25T03:02:15Z","timestamp":1122260535000},"page":"1401-1408","source":"Crossref","is-referenced-by-count":16,"title":["Anti-phospholipid antibodies in serum from patients with Guillain-Barr\u00e9 syndrome"],"prefix":"10.1007","volume":"31","author":[{"given":"G.","family":"Nakos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tziakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Maneta-Peyret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nassis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E.","family":"Lekka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,7,26]]},"reference":[{"key":"2736_CR1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(97)12308-X","volume":"352","author":"Hahn","year":"1998","unstructured":"Hahn AF (1998) Guillain-Barr\u00e9 syndrome. Lancet 352:635\u2013641","journal-title":"Lancet"},{"key":"2736_CR2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/088307380001500308","volume":"15","author":"Asbury","year":"2000","unstructured":"Asbury AK (2000) New concepts of Guillain-Barr\u00e9 syndrome. J Child Neurol 15:183\u2013191","journal-title":"J Child Neurol"},{"key":"2736_CR3","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1007\/s001340051093","volume":"25","author":"Gande","year":"1999","unstructured":"Gande AR, Taylor IR, Nolan KM (1999) Autonomic instability and hypertensionresulting in subarachnoid haemorrhage in the Guillain-Barr\u00e9 syndrome. Intensive Care Med 25:1432\u20131434","journal-title":"Intensive Care Med"},{"key":"2736_CR4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s001340051213","volume":"26","author":"Vargas","year":"2000","unstructured":"Vargas F, Hilbert G, Gruson D, Valentino R, Gbikpi-Benissan G, Cardinaud JP (2000) Fulminant Guillain-Barr\u00e9 syndrome mimicking cerebral death: case report and literature review. Intensive Care Med 26:623\u2013627","journal-title":"Intensive Care Med"},{"key":"2736_CR5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-510X(03)00029-7","volume":"210","author":"Odaka","year":"2003","unstructured":"Odaka M, Koga M, Yuki N, Susuki K, Hirata K (2003) Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barr\u00e9 syndrome onset subsequent to Campylobacter jejuni enteritis. J Neurol Sci 210:99\u2013103","journal-title":"J Neurol Sci"},{"key":"2736_CR6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ana.410340206","volume":"34","author":"Vriesendorp","year":"1993","unstructured":"Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL (1993) Serum antibodies to GMT, GD1b, peripheral nerve myelin, and Cambylobacter jejuni in patients with Guillain-Barr\u00e9 syndrome and controls: correlation and prognosis. Ann Neurol 34:130\u2013135","journal-title":"Ann Neurol"},{"key":"2736_CR7","doi-asserted-by":"crossref","unstructured":"Dowling PC, Cook SD (1981) Role of infection in Guillain-Barr\u00e9 syndrome: laboratory confirmation of hypersviruses in 41 cases. Ann Neurol 9 [Suppl]:44\u201345","DOI":"10.1002\/ana.410090709"},{"key":"2736_CR8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-5728(99)00159-9","volume":"102","author":"Neisser","year":"2000","unstructured":"Neisser A, Schwerer B, Bernheimer H, Moran AP (2000) Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barr\u00e9 syndrome. J Neuroimmunol 102:85\u201388","journal-title":"J Neuroimmunol"},{"key":"2736_CR9","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","volume":"333","author":"Rees","year":"1995","unstructured":"Rees JH, Soudain SE, Gregson NA, Hughes RAC (1995) Cambylobacter jejuni infection and Guillain-Barr\u00e9 syndrome. N Engl J Med 333:1374\u20131379","journal-title":"N Engl J Med"},{"key":"2736_CR10","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1128\/IAI.70.3.1202-1208.2002","volume":"333","author":"Ang","year":"2002","unstructured":"Ang CW, Laman JD, Willison HJ, Wagner ER, Endtz HP, De Klerk MA, Tio-Gillen AP, Van den Braak N, Jacobs BC, Van Doorn PA (2002) Structure of Cambylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barr\u00e9 and Miller Fisher patients. Infect Immun 333:1202\u20131208","journal-title":"Infect Immun"},{"key":"2736_CR11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","volume":"100","author":"Hughes","year":"1999","unstructured":"Hughes RAC, Hadden RD, Gregson NA, Smith KJ (1999) Pathogenesis of Guillain-Barr\u00e9 syndrome. J Neuroimmunol 100:74\u201397","journal-title":"J Neuroimmunol"},{"key":"2736_CR12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0022-510X(99)00173-2","volume":"168","author":"Carpo","year":"1999","unstructured":"Carpo M, Pedotti R, Allaria S, Lolli F, Mata S, Cavaletti G, Protti A, Pomati S, Scarlato G, Nobile-Orazio E (1999) Clinical presentation and outcome of Guillain-Barr\u00e9 and related syndromes in relation to anti-ganglioside antibodies. J Neurol Sci 168:78\u201384","journal-title":"J Neurol Sci"},{"key":"2736_CR13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","volume":"48","author":"Ogawara","year":"2000","unstructured":"Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M (2000) Axonal Guillain-Barr\u00e9 syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 48:624\u2013631","journal-title":"Ann Neurol"},{"key":"2736_CR14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-510X(01)00580-9","volume":"190","author":"Press","year":"2001","unstructured":"Press R, Mata S, Lolli F, Zhu J, Andersson T, Link H (2001) Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barr\u00e9 syndrome. J Neurol Sci 190:41\u201347","journal-title":"J Neurol Sci"},{"key":"2736_CR15","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00007890-200104270-00026","volume":"71","author":"Bulsara","year":"2001","unstructured":"Bulsara KR, Bron PW, Tuttle-Newhall JE, Clavien PA, Morgenlander J (2001) Guillain-Barr\u00e9 syndrome in organ and bone marrow transplant patients. Transplantation 71:1169\u20131172","journal-title":"Transplantation"},{"key":"2736_CR16","first-page":"1013","volume":"6","author":"Paparounas","year":"2004","unstructured":"Paparounas K (2004) Anti-GQ1b ganglioside antibody in peripheral nervous system disorders: pathophysiologic role and clinical relevance. Arch Neurol 6:1013\u20131016","journal-title":"Arch Neurol"},{"key":"2736_CR17","doi-asserted-by":"crossref","unstructured":"Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome. Ann Neurol 27 [Suppl]:S21\u2013S24","DOI":"10.1002\/ana.410270707"},{"key":"2736_CR18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2004.04.002","volume":"102","author":"Dalakas","year":"2004","unstructured":"Dalakas MC (2004) The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Pharmacol Ther 102:177\u2013193","journal-title":"Pharmacol Ther"},{"key":"2736_CR19","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1097\/00003246-200110000-00017","volume":"29","author":"Maneta-Peyret","year":"2001","unstructured":"Maneta-Peyret L, Kitsiouli Ei, Lekka ME, Nakos G, Cassagne C (2001) Autoantibodies to lipids in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Crit Care Med 29:1950\u20131954","journal-title":"Crit Care Med"},{"key":"2736_CR20","first-page":"39","volume":"29","author":"Maneta-Peyret","year":"1991","unstructured":"Maneta-Peyret L, Previsani C, Sultan Y, Bezian JH, Cassagne C (1991) Auto-antibodies against all the phospholipids: a comparative systematic study with systemic lupus erythematosus and healthy sera. Eur J Clin Chem Clin Biochem 29:39\u201343","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"2736_CR21","first-page":"1675","volume":"168","author":"Hanly","year":"2003","unstructured":"Hanly JG (2003) Anti-phospholipid syndrome: an overview. Can Med Assoc J 168:1675\u20131682","journal-title":"Can Med Assoc J"},{"key":"2736_CR22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1078\/0171-2985-00217","volume":"207","author":"Gaipl","year":"2003","unstructured":"Gaipl US, Beyer TD, Baumann I, Voll RE, Stach CM, Heyder P, Kalden JR, Manfredi A, Herrmann M (2003) Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal\u00b1implications for anti-phospholipid syndrome and systemic lupus erythematosus. Immunobiology 207:73\u201381","journal-title":"Immunobiology"},{"key":"2736_CR23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1081\/CEH-120015327","volume":"24","author":"Caso","year":"2002","unstructured":"Caso V, Panarelli P, Albi E, Viola-Magni MP, Parnetti L, Gallai V (2002) Phospholipid autoantibodies: time for a new immuno-assay? Clin Exp Hypertens 24:511\u2013516","journal-title":"Clin Exp Hypertens"},{"key":"2736_CR24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0165-2478(93)90082-D","volume":"35","author":"Maneta-Peyret","year":"1993","unstructured":"Maneta-Peyret L, Biron C, Previsani C, Moreau P, Cassagne JH, Cassagne C (1993) Demonstration that anti-phospholipid auto-antibodies react with both anionic and zwitterionic phospholipids. Immunol Lett 35:141\u2013146","journal-title":"Immunol Lett"},{"key":"2736_CR25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1023\/A:1023239904856","volume":"18","author":"Krause","year":"1998","unstructured":"Krause I, Blank M, Shoenfeld Y (1998) Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in na\u00efve mice. J Clin Immunol 18:52\u201360","journal-title":"J Clin Immunol"},{"key":"2736_CR26","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","volume":"125","author":"Willison","year":"2002","unstructured":"Willison HJ, Yuki N (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125:2591\u20132625","journal-title":"Brain"},{"key":"2736_CR27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/ard.44.4.281","volume":"49","author":"Harris","year":"1985","unstructured":"Harris EN, Gharavi AE, Mackworth-Young CG, Patel BM, Derue G, Hughes GR (1985) Lupoid sclerosis: a positive pathogenitic role for anti-phospholipid antibodies. Ann Rheum Dis 49:281\u2013283","journal-title":"Ann Rheum Dis"},{"key":"2736_CR28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1309\/JAMH-GDQ6-6BYK-DW6J","volume":"118","author":"Favaloro","year":"2002","unstructured":"Favaloro EJ, Silvestrini R (2002) Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am J Clin Pathol 118:548\u2013557","journal-title":"Am J Clin Pathol"},{"key":"2736_CR29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1001\/archneur.1986.00520060066020","volume":"43","author":"Korn-Lubetzki","year":"1986","unstructured":"Korn-Lubetzki I, Abramsky O (1986) Acute and chronic demyelinating inflammatory polyradiculopathy: association with autoimmune diseases and lymphocyte response to human neuritogenic protein. Arch Neurol 43:604\u2013608","journal-title":"Arch Neurol"},{"key":"2736_CR30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0165-5728(84)90019-5","volume":"6","author":"Hughes","year":"1984","unstructured":"Hughes RA, Gray IA, Gregson NA, Kadlubowski M, Kennedy M, Leibowitz S, Thompson H (1984) Immune responses to myelin antigens in Guillain-Barr\u00e9 syndrome. J Neuroimmunol 6:303\u2013312","journal-title":"J Neuroimmunol"},{"key":"2736_CR31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/(SICI)1098-1101(1998)13:4<155::AID-JCA3>3.0.CO;2-#","volume":"13","author":"Mata","year":"1998","unstructured":"Mata S, Avanzi G, Lombardo R, Cepparone F, Pinto F, Lolli F (1998) Anti-GM1, anti-central myelin proteins, and anti-cardiolipin autoantibodies during plasma-exchange in Guillain-Barr\u00e9 syndrome (GBS). J Clin Apheresis 13:155\u2013162","journal-title":"J Clin Apheresis"},{"key":"2736_CR32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/08916939309010644","volume":"16","author":"Gilburd","year":"1993","unstructured":"Gilburd B, Stein M, Tomer Y, Tanne D, Abramski O, Chapman Y, Ahiron A, Blank M, Shoenfeld Y (1993) Autoantibodies to phospholipids and brain extract in patients with the Guillain-Barr\u00e9 syndrome: cross-reactive or pathogenic? Autoimmunity 16:23\u201327","journal-title":"Autoimmunity"},{"key":"2736_CR33","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","volume":"40","author":"Hafer-Macko","year":"1966","unstructured":"Hafer-Macko C, Hsieh S-T, Li CY, Ho TW, Sheikh K, Cornblath DR, McKhann GM Asbury AK, Griffin JW (1966) Acute motor axonal neurophathy: an antibodies mediated attack on axolemma. Ann Neurol 40:635\u2013644","journal-title":"Ann Neurol"},{"key":"2736_CR34","first-page":"635","volume":"39","author":"Hafer-Marcko","year":"1966","unstructured":"Hafer-Marcko C, Sheikh K, Li CY, Ho TW et al (1966) Immune attack on the Schwann cell surface in acute inflammatory demyelinating poluneuropathy. Ann Neurol 39:635\u2013644","journal-title":"Ann Neurol"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-005-2736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-005-2736-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-005-2736-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T08:49:47Z","timestamp":1558601387000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-005-2736-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,26]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["2736"],"URL":"https:\/\/doi.org\/10.1007\/s00134-005-2736-8","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,26]]}}}